Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

The Gates Vaccine Innovation Award

Gates (Bill & Melinda) Foundation

Hundreds of thousands of lives each year could be saved by improved access to vaccines. Vaccines are cost-effective, safe, and proven to protect children from disease.

The winner of the 2013 Gates Vaccine Innovation Award was announced in Bill Gates’ 2013 annual letter. The Award recognizes the work of Ms. Margarida Matsinhe, a field officer for VillageReach, a nonprofit working to improve health care and immunization coverage in Mozambique.

Continued innovation is essential to overcoming persistent challenges in reaching more children with vaccines.

The Gates Vaccine Innovation Award will celebrate revolutionary ways children in the poorest parts of the world are immunized. The winning innovation will be recognized with a US $250,000 prize.

The Gates Vaccine Innovation Award is open to individuals from any discipline. Candidates from academic institutions, governments, health care facilities, research institutions, non-profit organizations and for-profit companies may be nominated.

We recognize that innovation in the delivery of vaccines can take many shapes. We are looking for ideas big or small that have resulted in tangible improvements in immunization coverage in developing country communities.

Nominees will be assessed on three broad criteria:

Developing country impact – The nominee should have contributed to the prevention, control, or elimination of vaccine-preventable disease through significant improvements in immunization quality and coverage among mothers and children in developing countries.
Innovation and creativity – The nominee should have applied imaginative and pioneering approaches to overcome difficult challenges to immunizing children and achieving impact. Innovation is not the same as invention. Even simple ideas applied in creative ways to overcome real-world challenges can be considered innovative.
Scale – The nominee’s innovation should be at scale or suitable to be implemented at scale within the nominee’s country and around the world.

Nominations are accepted on a continuous basis.

Specialties

Environmental & Life Sciences

Medical

Medical - Clinical Science

Social Sciences

International Opportunities

Medical - Basic Science

Medical - Translational

Eligibility Requirements

In order to qualify for consideration:

Nominations must be related to vaccine delivery and meet the criteria above
Nomination forms must be completed in English
The three essay questions should be answered within the font and word-limit requirements

Please note that nominations focused on innovation in the areas of science and research & development are not eligible for consideration. This award is focused only on achieving impact through innovative systems, processes, tools, and technologies leading to better immunization.

Sponsor Details

Sponsor Institute/Organizations: Gates (Bill & Melinda) Foundation

Address: 2099 Pennsylvania Ave, NW Suite 200 Washington DC 20006 USA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity